Central serous chorioretinopathy and glucocorticoids

Area of Science:

• Ophthalmology
• Endocrinology
• Retinal Diseases

Background:

• Central serous chorioretinopathy (CSC) is a common retinal condition causing subretinal fluid and detachment.
• CSC typically affects young to middle-aged men and is associated with conditions involving increased endogenous or exogenous glucocorticoids.
• These conditions include Cushing's syndrome, type-A behavior, stress, and pregnancy, all linked to hypercortisolism.

Purpose of the Study:

• To explore the association between central serous chorioretinopathy and glucocorticoid exposure.
• To determine if glucocorticoids play a role in the pathogenesis of CSC.
• To evaluate the safety and efficacy of glucocorticoid treatment for CSC.

Main Methods:

• Literature review of studies on central serous chorioretinopathy and glucocorticoid exposure.
• Analysis of clinical presentations and outcomes in CSC patients with varying glucocorticoid levels.
• Review of treatment outcomes for CSC, particularly concerning glucocorticoid administration.

Main Results:

• CSC has been observed in patients with endogenous hypercortisolism (Cushing's syndrome) and following stressful events.
• Numerous cases of CSC are reported during or after glucocorticoid treatment for various conditions.
• CSC associated with exogenous glucocorticoids shows less male predilection, more chronic/atypical forms, and frequent bilaterality.
• Glucocorticoid treatment for CSC can exacerbate the condition.

Conclusions:

• Glucocorticoids may be implicated in the development of central serous chorioretinopathy, though the exact mechanism is unclear.
• Glucocorticoids should be avoided in the treatment of central serous chorioretinopathy.
• Central serous chorioretinopathy should be recognized as a potential ocular complication of glucocorticoid therapy.